Key Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$571K Sell
3,834
-423
-10% -$59.4K 0.09% 171
2026
Q2
$538K Buy
4,257
+9
+0.2% +$1.19K 0.09% 179
2026
Q1
$592K Sell
4,248
-10
-0.2% -$1.4K 0.11% 160
2025
Q4
$523K Hold
4,258
– – 0.1% 168
2025
Q3
$473K Buy
4,258
+5
+0.1% +$568 0.09% 175
2025
Q2
$472K Hold
4,253
– – 0.09% 170
2025
Q1
$477K Hold
4,253
– – 0.1% 160
2024
Q4
$393K Buy
4,253
+20
+0.5% +$1.8K 0.09% 171
2024
Q3
$355K Buy
4,233
+5
+0.1% +$382 0.08% 189
2024
Q2
$290K Sell
4,228
-130
-3% -$8.68K 0.07% 197
2024
Q1
$319K Hold
4,358
– – 0.08% 182
2023
Q4
$353K Sell
4,358
-50
-1% -$3.89K 0.1% 158
2023
Q3
$330K Hold
4,408
– – 0.11% 150
2023
Q2
$340K Buy
4,408
+130
+3% +$10.4K 0.11% 149
2023
Q1
$355K Hold
4,278
– – 0.13% 137
2022
Q4
$264K Hold
4,278
– – 0.12% 137
2022
Q3
$264K Hold
4,278
– – 0.12% 139
2022
Q2
$267K Hold
4,278
– – 0.14% 125
2022
Q1
$254K Buy
4,278
+50
+1% +$3.2K 0.13% 130
2021
Q4
$307K Buy
4,228
+151
+4% +$10.4K 0.15% 112
2021
Q3
$285K Hold
4,077
– – 0.16% 115
2021
Q2
$278K Buy
4,077
+17
+0.4% +$1.14K 0.16% 116
2021
Q1
$262K Buy
4,060
+26
+0.6% +$1.68K 0.17% 115
2020
Q4
$235K Hold
4,034
– – 0.17% 109
2020
Q3
$255K Hold
4,034
– – 0.26% 91
2020
Q2
$301K Hold
4,034
– – 0.35% 74
2020
Q1
$306K Hold
4,034
– – 0.31% 59
2019
Q4
$262K Buy
+4,034
New +$263K 0.25% 86

Other funds holding GILD

Key Financial's GILD Position: Q3 2026 in Review

Key Financial reduced its Gilead Sciences (GILD) stake by 9.9% in Q3 2026, selling an estimated $59.4K and leaving 3,834 shares worth $571K. The position accounts for 0.09% of the portfolio, ranked #171.

Key Financial first reported a position in GILD in Q4 2019 and has held it in 28 quarters since. The position peaked at $592K in Q1 2026. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Key Financial held 3,834 shares of Gilead Sciences worth $571K as of Q3 2026.
  • Key Financial sold 423 Gilead Sciences shares in Q3 2026, an estimated $59.4K.
  • Gilead Sciences made up 0.09% of Key Financial's portfolio in Q3 2026, its #171 holding.
  • Key Financial first reported a position in Gilead Sciences in Q4 2019 and has held it in 28 quarters since.
  • Key Financial's Gilead Sciences position peaked at $592K in Q1 2026.
  • 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.